Luigi Di Lauro

Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide

Paola Papaldo, Massimo Lopez, Paolo Marolla et al. · Journal of Clinical Oncology · 2005 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Paola Papaldo, Massimo Lopez, Enrico Cortesi et al. · Journal of Clinical Oncology · 2003 · 75 citations

Medicine, Oncology, Pharmacology +16

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Patrizia Vici, Laura Pizzuti, Andrea Michelotti et al. · Oncotarget · 2017 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Hormonal Treatment of Disseminated Male Breast Cancer

Massimo Lopez, Luigi Di Lauro, Bonaventura Lazzaro et al. · Oncology · 2009 · 57 citations

Medicine, Endocrinology, Oncology +13

Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study

Teresa Gamucci, Andrea Michelotti, Laura Pizzuti et al. · Journal of Cancer · 2014 · 57 citations · Full text

Medicine, Oncology, Pharmacology +14